Scientific Evaluation of ViraImmune
ViraImmune is a flavonoid-centered research formulation developed by AMH Biotech LLC and evaluated through integrated computational and experimental methodologies.
The ViraImmune framework focuses on:
- Molecular docking
- LigPlot+ interaction analysis
- Surface Plasmon Resonance (SPR)
- Enzyme inhibition assays
Cell-based validation systems
Hesperidin as a Lead Flavonoid
Among evaluated compounds, Hesperidin emerged as a primary lead candidate based on:
- Strong TMPRSS2 interaction
- Stable Mpro binding
- Multi-target interaction profile
- Experimental validation support
Surface Plasmon Resonance (SPR)
SPR analysis demonstrated measurable ligand-protein interaction behavior for selected flavonoids.
Hesperidin demonstrated:
- Stronger binding response
- Sustained interaction behavior
More stable association profiles compared with Rutin
Docking and LigPlot+ Analysis
Computational docking using AutoDock Vina and LigPlot+ identified interaction networks involving:
- Hydrogen bonds
- Hydrophobic contacts
- Catalytic-site interactions
- Multi-point anchoring patterns
Influenza-Relevant Targets
ViraImmune-related flavonoids were also evaluated against influenza viral proteins.
Research findings included:
- Moderate Hesperidin interaction with hemagglutinin (HA)
- Strong Rutin interaction with neuraminidase (NA)
Mechanism-Based Framework
The scientific evidence supporting ViraImmune emphasizes:
- Multi-target evaluation
- High-purity flavonoid research
- Mechanistic analysis rather than generalized botanical claims
AMH - BIOTECH
